Consistent with this, liver hepcidin (Hamp1) expression and serum hepcidin concentrations were reduced in anti-BMP6-treated myeloma-bearing mice, and serum iron and haemoglobin concentrations were increased (Supplementary Fig. 12). Here, BMP6 is linked to plasma cell myeloma.